Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe

Journals Blog

  • Visit AAP News on Facebook
  • Follow AAP News on Twitter

Antibiotics for Viral Acute Respiratory Tract Infections: Going, Going, and Hopefully Gone

Lewis First, MD, MS, Editor in Chief, Pediatrics
February 12, 2021

Antibiotic stewardship has been a frequent topic for studies and commentaries in our journal. Still, it can be challenging not to prescribe antibiotics even when the potential benefit is small. What do we know about delaying antibiotics to ensure that they are really needed? Mas-Dalmau et al (10.1542/peds.2020-1323) share with us the results of a randomized clinical trial in Spain involving 436 patients ages 2-14 years-old seen in 39 primary care centers with acute otitis, pharyngitis, rhinosinusitis, or acute bronchitis and whose providers had some doubts about whether antibiotics were needed. The investigators randomized these children into three groups to receive (1) an immediate prescription for an oral antibiotic; (2) a delayed prescription for antibiotic use if symptoms did not improve after a set period of time; or (3) no antibiotic prescription. The primary outcomes were symptom duration and severity and secondary outcomes were use of antibiotics in the delayed and no antibiotic categories parent satisfaction, and parent beliefs regarding the importance of using antibiotics for ARTIs. The results for all these outcomes are shared in detail in this study, but the bottom line is that there were no meaningful differences in duration or severity of symptoms regardless of group. Furthermore, only parents in the immediate prescription group that felt like antibiotics made a difference, even though there was no clinical difference.

So, does this mean we should not use antibiotics at all for treatment of uncomplicated ARTIs? To answer that question, and to comment on the implications of this study, we asked infectious disease expert Dr. Jeffrey Gerber and clinical effectiveness specialists Dr. Bonnie Offit from the Children’s Hospital of Philadelphia to weigh in with an accompanying commentary (10.1542/peds.2020-046839). They point out that since pharyngitis should not be treated unless a rapid strep assay or culture is positive; since “bronchitis” (which is still not well defined in children) is viral; and since sinusitis and otitis already have delayed options for use of antibiotics per evidence-based clinical practice guidelines and guidelines, we should spend far more time educating families about ARTIs and their typical viral course rather than overprescribe antibiotics for these disorders. Prescribe some time for yourself to read this article and commentary and then consider whether there are more opportunities to reduce antibiotic use in ARTIs than you are already doing in your practice.

  • Reducing Antibiotic Prescribing in Primary Care for Respiratory Illness
  • A Quality Improvement Initiative To Optimize Antibiotic Use in a Level 4 NICU
  • A Quality Improvement Initiative To Optimize Antibiotic Use in a Level 4 NICU
  • Facebook
  • Instagram
Copyright © 2021 American Academy of Pediatrics

Advertising Disclaimer »

Download PDF
Share
Antibiotics for Viral Acute Respiratory Tract Infections: Going, Going, and Hopefully Gone
Lewis First, MD, MS
February 12, 2021
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Email Blog Post

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antibiotics for Viral Acute Respiratory Tract Infections: Going, Going, and Hopefully Gone
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Digital Edition Current Issue
  • Latest Daily News
  • Archives
  • Collections
  • Columns
  • Advertising
  • Subscribe to AAP News Magazine
  • Terms of Use
  • Privacy Statement
  • FAQ
  • Contact Us
  • 2021 AAP Journals Catalog
  • Pediatrics
  • Pediatrics in Review
  • Hospital Pediatrics
  • NeoReviews
  • AAP Grand Rounds
  • AAP Career Center
  • shopAAP
  • AAP.org
  • AAP News
  • Visit AAP News on Facebook
  • Follow AAP News on Twitter
American Academy of Pediatrics

© 2021 American Academy of Pediatrics